Arcutis Biotherapeutics, Inc.

This study tested a cream called ARQ-151 in 652 children aged 2 to 5 years with eczema (atopic dermatitis). The cream was applied once daily for 4 weeks. The goal was to see if it could clear or nearly clear the skin rash better than a cream with no active ingredient. The study i…

This study tested a cream called roflumilast (0.05%) applied once daily for 4 weeks in 101 infants aged 3 months to under 2 years with mild to moderate eczema. The main goal was to check for side effects and skin reactions. The cream is not a cure, but aims to ease symptoms safel…

This study looked at the long-term safety of a cream called roflumilast for people with mild to moderate eczema (atopic dermatitis). Over 1,200 children and adults applied the cream once daily for up to 52 weeks. The main goal was to track any side effects, with secondary goals m…